Orion Market Research (OMR) recently published a market research report on the global Next Generation Cancer Diagnostics Market. The market is segmented on the basis of application, technology and end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, regulations, market determinants, key company analysis, strategic analysis, market insights, company profiling, market segmentation, and geographical analysis.

Full report of the global next generation cancer diagnostics market is available at: https://www.omrglobal.com/industry-reports/next-generation-cancer-diagnostics-market/

In the past days, cancer was considered as one of the lethal diseases. However, with the passage of time and medical advancements, various new diagnostic methods for cancer are discovered due to which the disease remained no more fatal. In the recent days, next-generation sequencing is employed as a diagnostic tool, which is used to analyze the genome sequences occurring in cancer. This generation sequencing technique employs various other technologies such as DNA micro arrays, protein micro arrays, lab-on-a-chip and reverse transcriptase-PCR, and next-generation sequencing for cancer diagnosis. The increased number of research projects and funding on oncology, due to the increasing prevalence of oncological disorders, globally, is one of the major motivators driving the market.

Visit here to know more about Next Generation Cancer Diagnostics Market study

Apart from the increase in prevalence of oncological disorders, increased demand for the personalized medicines along with the increase in deployment of tumor diagnostics in CTC analysis is further boosting the market growth. In addition, the government initiatives taken towards the development of the advanced cancer diagnostic methods are driving the market. The report focuses on various other market trends, such as adoption of LabSat TM, which is a new advanced next-generation equipment employed in tissue diagnostics and cancer research. The report also provides analysis on leading players, key developments, future strategies and technological advancements. The key players present in the market include Biospherex LLC, Agilent Technologies, Inc., General Electric Co., Lunaphore Technologies S.A., Cepheid, F. Hoffmann-La Roche Ltd, QIAGEN N.V., and Thermo Fisher Scientific Inc., among others.

Region Covered
• North America (US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, and Japan)
• Rest of the World

Market Segmentation
1. Global Next Generation Cancer Diagnostics Market by Technology
• Next Generation Sequencing
• QPCR & Multiplexing
• Protein Microarrays
• DNA Microarrays
• Others [Lab-on- a- chip & Reverse Transcriptase-PCR (RT-PCR)]

2. Global Next Generation Cancer Diagnostics Market by Application
• Biomarker Development
• Proteomic Analysis
• Cancer Screening
• Others (CTC Analysis)

3. Global Next Generation Cancer Diagnostics Market by End-User
• Hospitals & Clinics
• Research Centers

For Free Sample Reports: https://www.omrglobal.com/request-sample/next-generation-cancer-diagnostics-market

For related reports please visit:
• Optogenetics Actuators and Sensors Market
• Cell expansion market

About Orion Market Research
Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667,+91 780-304-0404